Dr. Yae K Suh, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1001 N Tustin Ave, Santa Ana, CA 92705 Phone: 714-953-3381 Fax: 714-953-3541 |
Khodadad Mehraein, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1415 E 17th St, Suite 280, Santa Ana, CA 92705 Phone: 562-225-2002 Fax: 949-415-2536 |
Shahin H Samimi, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2701 S Bristol St, Santa Ana, CA 92704 Phone: 714-754-5454 Fax: 714-979-7284 |
Gholamhossei Pezeshkpour, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1001 N Tustin Ave, Santa Ana, CA 92705 Phone: 714-835-3555 Fax: 714-953-3541 |
Mr. Khalil Sheibani, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1001 N Tustin Ave, Santa Ana, CA 92705 Phone: 714-953-3381 Fax: 714-953-3541 |
News Archive
Factors other than genetics and childhood environment affect the risk of going on medical leave or disability pension, reports a study in the January Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg tablets.
A vision screening law targeting Florida drivers age 80 and older appears to be associated with lower death rates from motor vehicle collisions in this age group, despite little evidence of an association between vision and car crashes, according to a report in the November issue of Archives of Ophthalmology , one of the JAMA/Archives journals.
The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.
› Verified 5 days ago